Vanda Pharmaceuticals (VNDA) Net Income towards Common Stockholders Growth (1y) (2011 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Net Income Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - | -58.11% |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - | - |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn | -95.76% |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - | - |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - | -290.15% |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn | 59.59% |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - | -129.68% |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn | -10.08% |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn | 1,228.66% |
| 10 | Vanda Pharmaceuticals | 379.35 Mn | 177.04 Mn | 48.56 Mn | -64.52% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -64.52% |
| Dec 31, 2025 | -2,796.41% |
| Sep 30, 2025 | -322.72% |
| Jun 30, 2025 | -501.75% |
| Mar 31, 2025 | -608.31% |
| Dec 31, 2024 | -103.93% |
| Sep 30, 2024 | -4,000.73% |
| Jun 30, 2024 | -402.82% |
| Mar 31, 2024 | -229.00% |
| Dec 31, 2023 | -134.85% |
| Sep 30, 2023 | -95.80% |
| Jun 30, 2023 | -42.39% |
| Mar 31, 2023 | 150.20% |
| Dec 31, 2022 | -3.07% |
| Sep 30, 2022 | -58.04% |
| Jun 30, 2022 | -73.17% |
| Mar 31, 2022 | -174.34% |
| Dec 31, 2021 | -13.75% |
| Sep 30, 2021 | 30.67% |
| Jun 30, 2021 | 11.09% |
| Mar 31, 2021 | 1,679.84% |
| Dec 31, 2020 | 93.77% |
| Sep 30, 2020 | -94.08% |
| Jun 30, 2020 | -24.61% |
| Mar 31, 2020 | 179.41% |
| Dec 31, 2019 | -59.20% |
| Sep 30, 2019 | 1,301.97% |
| Jun 30, 2019 | 149.97% |
| Mar 31, 2019 | -119.96% |
| Dec 31, 2018 | 664.74% |
| Sep 30, 2018 | 257.43% |
| Jun 30, 2018 | 400.59% |
| Mar 31, 2018 | 140.10% |
| Dec 31, 2017 | -267.60% |
| Sep 30, 2017 | -958.14% |
| Jun 30, 2017 | 66.78% |
| Mar 31, 2017 | 38.14% |
| Dec 31, 2016 | 96.64% |
| Sep 30, 2016 | 95.49% |
| Jun 30, 2016 | 15.39% |
| Mar 31, 2016 | -20.06% |
| Dec 31, 2015 | -121.37% |
| Sep 30, 2015 | -558.91% |
| Jun 30, 2015 | 74.70% |
| Mar 31, 2015 | 61.21% |
| Dec 31, 2014 | 1,014.25% |
| Sep 30, 2014 | 73.09% |
| Jun 30, 2014 | -537.75% |
| Mar 31, 2014 | -487.14% |
| Dec 31, 2013 | -137.47% |
| Sep 30, 2013 | -1.01% |
| Jun 30, 2013 | 57.75% |
| Mar 31, 2013 | 43.24% |
| Dec 31, 2012 | 468.31% |
| Sep 30, 2012 | -73.26% |
| Jun 30, 2012 | -497.09% |
| Mar 31, 2012 | -5,954.41% |
| Dec 31, 2011 | -297.89% |
| Sep 30, 2011 | -196.55% |
| Jun 30, 2011 | -204.77% |